Show results for
Refine by
Clinical Pregnancy And Implementation Success Rates For Ivf Clinics Services In Usa
14 services found
by:Inteliquet, An IQVIA Business based inDover, DELAWARE (USA)
Underpinning Inteliquet’s sophisticated technology are Clinical Engagement teams. After successful implementation of OncWeb, cancer centers are part of Inteliquet’s Consortium. Dedicated teams of clinical engagement specialists work with each Consortium center to ensure users are empowered to realize the platform’s full potential and offer various support services. ...
Manufactured by:Siemens Healthcare GmbH based inErlangen, GERMANY
The pivotal, multi-center PRECISE trial demonstrated the safety and feasibility of the remote-controlled CorPath 200 System for use during PCI. The study met its clinical and technical endpoints, with the operator experiencing a significant reduction in radiation exposure. There were no reports of device-related complications and an overall clinical success rate of 97.6%. The average radiation ...
Manufactured by:GC America Inc. based inAlsip, ILLINOIS (USA)
Digital technology is one of the fastest-growing segments of the dental market worldwide and digital processes are increasingly determining everyday practice in dental offices and laboratories. GC has taken a leading role in promoting and supporting the expansion of the digital highway, as we are convinced that it will bring further progress to ...
Manufactured by:Ivenix, Inc. based inNorth Andover, MASSACHUSETTS (USA)
Technical team efficiency and success. Today, clinical engineering and IT staff face ever-evolving challenges managing infusion device integration and maintaining sizable pump fleets. Juggling multiple projects and priorities, these teams are busy ensuring technology delivers peak performance, is constantly updated and operates ...
Manufactured by:Siemens Healthcare GmbH based inErlangen, GERMANY
The PRECISION Study was a multicenter, post-market registry of robotic PCI using the Corindus CorPath 200 System. The purpose of the study was to collect data on the routine patterns of use, safety and effectiveness, including the clinical and technical performance of the CorPath 200 System, in the delivery and manipulation of coronary guidewires and stent/balloon catheters during PCI ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Why partner with Signatera for your clinical trial? Clinically validated across multiple solid tumors, Signatera has shown to predict relapse in >98% of patients without further treatment. Experienced team with Global reach: CE Mark, three FDA Breakthrough Device Designations, 8 Non-Significant Risk (NSR) determinations. >60 Natera IP assets covering ctDNA MRD and ...
by:Medidata based inNew York, NEW YORK (USA)
Imagine the possibilities of partnering with a team of industry experts who helps you drive digital transformation, change management, and decentralized clinical trials. A team that provides cutting-edge strategic design drives operational performance, develops value-based outcomes, and helps implement your long-term strategy. A team that helps you to solve the impossible. This is what the ...
Manufactured by:Advanced Cell Diagnostics, Inc. based inNewark, CALIFORNIA (USA)
There is growing interest in RNA-based biomarkers and measuring RNA expression holds great promise for stratifying patients based on drug response, drug efficacy and risk of side effects. RNAscope in situ hybridization enables molecular detection in a morphological context. It provides the cellular resolution required to evaluate tissue heterogeneity and to potentially better screen and select ...
by:PathAI, Inc. based inBoston, MASSACHUSETTS (USA)
Enable clinical trial success powered by our trial-ready algorithms, comprehensive lab services, and experienced clinical operations ...
Manufactured by:UroTech based inFranklin, TENNESSEE (USA)
UroTech is devoted to keeping pace with the growing need for better and more widespread brachytherapy services. Like UroTech's thermotherapy and lithotripsy services, UroTech delivers top of the line equipment and expertise to facilities seeking to improve their services for prostate cancer. We work hand in hand with radiation oncologists, physicists, and urologists to develop Centers of ...
Manufactured by:AnaBios Corporation based inSan Diego, CALIFORNIA (USA)
EX VIVO Human Platforms for Cardiovascular Drug Discovery. Broadly defined, cardiovascular disease is the leading cause of death for men and women across most racial and ethnic groups in the United States with one person dying approximately every 34 seconds1. To drive successful clinical translation of new cardiovascular medicine, AnaBios develops relevant human ex vivo platforms for many ...
by:Freyr Solutions based inPrinceton, NEW JERSEY (USA)
After years of successful clinical research, submission of documents for Health Authority (HA) review requires a specialized skill of clear and precise clinical report writing. Such clear and precise clinical writing aids reviewers to easily comprehend the technicalities of clinical research, as a single error in clinical documentation may prove risky and costly for organizations, causing delays ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
A key step in drug discovery is target identification—identifying "druggable" biological targets. After a target is identified, it must be validated to demonstrate the functional relationship between the target and disease phenotype while ensuring safety. The drug discovery process is lengthy and costly, but good target validation increases the likelihood of developing effective drugs and ...
Manufactured by:XILIS, Inc. based inDurham, NORTH CAROLINA (USA)
Xilis’ rapid and scalable patient-derived MicroOrganoSphere (MOS) technology platform enhances precision medicine and pharmaceutical drug discovery and development. Compared to conventional patient-derived models, MOS provides faster, higher-throughput, and greater cost savings, as well as more predictive and accurate results. MOS can be used in large-scale pharmacogenomic studies that are ...